Boston Scientific to buy Minnesota company - The Boston Globe

Boston Scientific Corp. has reached a deal to buy Relievant Medsystems, a Minnesota-based maker of devices that treat chronic low back pain, with an upfront cash payment of $850 million and ... Read More

Boston Scientific cuts Houston jobs, moves work to Minnesota - Boston Business Journal

The cuts follow Boston Scientific's 2021 acquisition of Minnesota-based Preventice Solutions, which originally owned the Sam Houston Parkway building. Boston Business Journal Select a City ... Read More

Boston Scientific to Buy Silk Road Medical for $1.26B

In a news release, Boston Scientific said the enterprise value of the deal would come to $1.16 billion including Silk Road’s current net cash position of $101 million. Read More

Boston Scientific Stock Flirts With A Buy Point, Once Again - MSN

Boston Scientific topped first-quarter earnings and sales estimates April 23. It also raised its full-year 2025 profit outlook to a range of $2.87 to $2.94 per share, and now expects net sales to ... Read More

Boston Scientific (BSX) Upgraded to Buy: Here's Why - Yahoo Finance

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Read More

Boston Scientific acquires urology company Axonics for $3.7 billion

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion. It’s the first billion-dollar medical device deal of ... Read More

Boston Scientific to Buy Medical-Technology Company Cortex

News; Global News Select; Boston Scientific to Buy Medical-Technology Company Cortex. Boston Scientific to Buy Medical-Technology Company Cortex Provided by Dow Jones Nov 4, 2024, 1:01:00 PM. Read More

Truist lifts Boston Scientific stock target to $120, maintains Buy - MSN

On Thursday, Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently ... Read More

Boston Scientific expansion nears construction, up for DEED award

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in awards from the Minnesota Department of Employment and Economic ... Read More

Buy Rating for Boston Scientific: Growth, Innovation, and Market Leadership Fuel Optimistic Outlook

In a report released on August 28, David Rescott from Robert W. Baird assigned a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $91.00. David Rescott has given ... Read More

Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Read More